TGTX

Tg Therapeutics Stock Analysis

AI Rating

Fair
  • Quality7/10
  • Growth↓ 0/10
  • Momentum↓ 4/10
Tg Therapeutics sales and earnings growth
TGTX Growth
Low
  • Revenue Y/Y↑ 100.88%
  • EPS Y/Y↑ 3511.11%
  • FCF Y/Y↓ -149.88%
Tg Therapeutics gross and profit margin trends
TGTX Profitability
Good
  • Gross margin ↑ 85.30%
  • EPS margin↑ 84.10%
  • ROIC↑ 16.00%
Tg Therapeutics net debt vs free cash flow
TGTX Risk
Great
  • Debt / Equity↓ 0.4
  • Debt / FCF↓ 2.5
  • Interest coverage↓ 4.2

Tg Therapeutics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗